A consortium of major healthcare systems forms to develop and rigorously validate Diagnostic AI solutions for FDA clearance.
1 report, 1 independent
Updated Aug 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A consortium of major healthcare systems forms to develop and rigorously validate Diagnostic AI solutions for FDA clearance.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
consortium
association of two or more individuals, companies, organizations or governments (or any combination of these entities)
Nothing else this week.
- FDA
Related events
- FDA is willing to review updated submissions, while biotech hubs leverage AI to ease clinical development bottlenecks.
- A company involving Oxford seeks FDA clearance for a new diagnostic test.
- Zenith collaborates with Harvard researchers on clinical studies, receiving FDA clearance for the trial.
- Congress introduced AI legislation, CMS expanded value-based models, FDA built AI infrastructure, and FTC rescinded a health data breach policy.
- FDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.